Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Lenvatinib Plus Camrelizumab versus Lenvatinib Monotherapy as Post-Progression Treatment for Advanced Hepatocellular Carcinoma: A Short-Term Prognostic Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,847 | Dovepress* | 4,291+ | 732 | 5,023 | |
| PubMed Central* | 556 | 283 | 839 | ||
| Totals | 4,847 | 1,015 | 5,862 | ||
| *Since 27 May 2021 | |||||
View citations on PubMed Central and Google Scholar